These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2280604)

  • 1. Biochemical basis of the prevention of 6-thiopurine toxicity by the nucleobases, hypoxanthine and adenine.
    Hashimoto H; Kubota M; Shimizu T; Takimoto T; Kitoh T; Akiyama Y; Mikawa H
    Leuk Res; 1990; 14(11-12):1061-6. PubMed ID: 2280604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxanthine incorporation and nucleotide imbalance in wild-type and adenine phosphoribosyl transferase-deficient Friend leukaemia cells.
    Amara FM; Wilkinson YA; Gilmore WS; McKenna PG
    Biochem Soc Trans; 1990 Aug; 18(4):618. PubMed ID: 2276470
    [No Abstract]   [Full Text] [Related]  

  • 3. Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells.
    Adamson PC; Balis FM; Hawkins ME; Murphy RF; Poplack DG
    Biochem Pharmacol; 1993 Nov; 46(9):1627-36. PubMed ID: 8240420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro.
    Liliemark J; Pettersson B; Peterson C
    Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of 2-amino-6-chloro-1-deazapurine.
    Bennett LL; Smithers D; Rose LM; Adamson DJ; Brockman RW
    Biochem Pharmacol; 1984 Jan; 33(2):261-71. PubMed ID: 6142712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):64-70. PubMed ID: 14342250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
    Zimm S; Johnson GE; Poplack DG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells.
    Morgan CJ; Chawdry RN; Smith AR; Siravo-Sagraves G; Trewyn RW
    Cancer Res; 1994 Oct; 54(20):5387-93. PubMed ID: 7923170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-ethylmercaptopurine-mediated growth inhibition of HL-60 cells in vitro irrespective of purine salvage.
    Gibboney DS; French BT; Patrick DE; Trewyn RW
    Cancer Chemother Pharmacol; 1989; 25(3):189-94. PubMed ID: 2598410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenine-induced hypoxanthine release from IMP-enriched human erythrocytes.
    Giacomello A; Salerno C
    Biochim Biophys Acta; 1983 Apr; 756(3):403-6. PubMed ID: 6830863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a hypoxanthine guanine phosphoribosyl transferase deficient human promyelocytic leukemia cell mutant.
    Liu YH; Xue SP
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(3):149-56. PubMed ID: 3064088
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 6-mercaptopurine in human leukemic cells.
    Higuchi T; Nakamura T; Wakisaka G
    Cancer Res; 1976 Oct; 36(10):3779-83. PubMed ID: 821607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and preliminary characterization of drug resistant mutants of human lymphoblastoid cells.
    Duncan ME
    Cytobios; 1977; 19(73):45-66. PubMed ID: 616807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine synthesis and excretion in mutants of the WI-L2 human lymphoblastoid line deficient in adenosine kinase (AK) and adenine phosphoribosyltransferase (APRT).
    Hershfield MS; Spector EB; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():303-13. PubMed ID: 193373
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine.
    Dervieux T; Hancock M; Evans W; Pui CH; Relling MV
    Leukemia; 2002 Feb; 16(2):209-12. PubMed ID: 11840287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of nutritional state and allopurinol on nucleotide formation in enterocytes from the guinea pig small intestine.
    Gross CJ; Savaiano DA
    Biochim Biophys Acta; 1991 Mar; 1073(2):260-7. PubMed ID: 2009279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.